Innovation Under Regulatory Uncertainty: Evidence from Medical Technology

@inproceedings{Stern2016InnovationUR,
  title={Innovation Under Regulatory Uncertainty: Evidence from Medical Technology},
  author={Ariel Dora Stern},
  year={2016}
}
This paper explores how the regulatory approval process affects innovation incentives in medical technologies. Prior studies have found early mover regulatory advantages for drugs. I find the opposite for medical devices, where pioneer entrants spend 34 percent (7.2 months) longer than follow-on entrants in regulatory approval. Back-of-the-envelope calculations suggest that the cost of a delay of this length is upwards of 7 percent of the total cost of bringing a new high-risk device to market… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 14 CITATIONS